# Clinical Performance of the Investigational GEM Hemochron® 100 in Populations Ages 18 Years and Older

> **NCT03074266** · — · UNKNOWN · sponsor: **Accriva Diagnostics** · enrollment: 140 (estimated)

## Conditions studied

- Blood Coagulation Test

## Interventions

- **DIAGNOSTIC_TEST:** GEM Hemochron 100 ACT

## Key facts

- **NCT ID:** NCT03074266
- **Lead sponsor:** Accriva Diagnostics
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-06-08
- **Primary completion:** 2018-12
- **Final completion:** 2018-12
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2018-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03074266

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03074266, "Clinical Performance of the Investigational GEM Hemochron® 100 in Populations Ages 18 Years and Older". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03074266. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*